Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease

References

• MurrayCJLopezADAlternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyLancet19973499064149815049167458
   PubMed Web of Science ®Google Scholar
• OgaTNishimuraKTsukinoMSatoSHajiroTAnalysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health statusAm J Respir Crit Care Med2003167454454912446268
   PubMed Web of Science ®Google Scholar
• Pinto-PlataVMCoteCCabralHTaylorJCelliBRThe 6-min walk distance: change over time and value as a predictor of survival in severe COPDEur Respir J2004231283314738227
   PubMed Web of Science ®Google Scholar
• PittaFTroostersTSpruitMAProbstVSDecramerMGosselinkRCharacteristics of physical activities in daily life in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171997297715665324
   PubMed Web of Science ®Google Scholar
• MinakataYSuginoAKandaMReduced level of physical activity in Japanese patients with chronic obstructive pulmonary diseaseRespir Investig20145214148
   Google Scholar
• WaschkiBKirstenAHolzOPhysical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort studyChest2011140233134221273294
   PubMed Web of Science ®Google Scholar
• RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
   PubMed Web of Science ®Google Scholar
• DonohueJFFogartyCLötvallJINHANCE Study InvestigatorsOnce-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropiumAm J Respir Crit Care Med2010182215516220463178
   PubMed Web of Science ®Google Scholar
• KinoshitaMLeeSHHangLWIndacaterol Asian COPD Study InvestigatorsEfficacy and safety of indacaterol 150 and 300 μg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: a 12-week, placebo-controlled studyRespirology201217237938922122202
   PubMed Web of Science ®Google Scholar
• ToYKinoshitaMLeeSHAssessing efficacy of indacaterol in moderate and severe COPD patients: a 12-week study in an Asian populationRespir Med2012106121715172123040786
   PubMed Web of Science ®Google Scholar
• KornmannODahlRCentanniSINLIGHT-2 (Indacaterol Efficacy Evaluation Using 150-μg Doses with COPD Patients) study investigatorsOnce-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparisonEur Respir J201137227327920693243
   PubMed Web of Science ®Google Scholar
• BuhlRDunnLJDisdierCINTENSITY study investigatorsBlinded 12-week comparison of once-daily indacaterol and tiotropium in COPDEur Respir J201138479780321622587
   PubMed Web of Science ®Google Scholar
• BeehKMWagnerFKhindriSDrollmannAFEffect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPDCOPD20118534034521793716
   PubMedGoogle Scholar
• O’DonnellDECasaburiRVinckenWINABLE 1 study groupEffect of indacaterol on exercise endurance and lung hyperinflation in COPDRespir Med201110571030103621498063
   PubMed Web of Science ®Google Scholar
• WatzHKrippnerFKirstenAMagnussenHVogelmeierCIndacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease – a randomized, multicenter, double-blind, placebo-controlled studyBMC Pulm Med201414115825280934
   PubMed Web of Science ®Google Scholar
• HatajiONaitoMItoKWatanabeFGabazzaECTaguchiOIndacaterol improves daily physical activity in patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis201381523293514
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010 Available from: http://www.goldcopd.org/
   Google Scholar
• KumaharaHSchutzYAyabeMThe use of uniaxial accelerometry for the assessment of physical-activity-related energy expenditure: a validation study against whole-body indirect calorimetryBr J Nutr20049123524314756909
   PubMed Web of Science ®Google Scholar
• SuginoAMinakataYKandaMValidation of a compact motion sensor for the measurement of physical activity in patients with chronic obstructive pulmonary diseaseRespiration201283430030721912085
   PubMed Web of Science ®Google Scholar
• CelliBRMacNeeWATS / ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of ATS / ERS position paperEur Respir J200423693294615219010
   PubMed Web of Science ®Google Scholar
• JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• TsudaTSuematsuRKamoharaKDevelopment of the Japanese version of the COPD Assessment TestRespir Investig20125023439
   PubMedGoogle Scholar
• FukuharaSBitoSGreenJHsiaoAKurokawaKTranslation, adaptation, and validation of the SF-36 Health Survey for use in JapanJ Clin Epidemiol19985111103710449817121
   PubMed Web of Science ®Google Scholar
• FukuharaSWareJEJrKosinskiMWadaSGandekBPsychometric and clinical tests of validity of the Japanese SF-36 Health SurveyJ Clin Epidemiol19985111104510539817122
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEuro Respir J200526319338
   PubMed Web of Science ®Google Scholar
• Tudor-LockeCBurkettLReisJPAinsworthBEMaceraCAWilsonDKHow many days of pedometer monitoring predict weekly physical activity in adults?Prev Med200540329329815533542
   PubMed Web of Science ®Google Scholar
• SteeleBGHoltLBelzaBFerrisSLakshminaryanSBuchnerDMQuantitating physical activity in COPD using a triaxial accelerometerChest200011751359136710807823
   PubMed Web of Science ®Google Scholar